Portfolio company
Tetra Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops therapeutic drugs for patients suffering from neurological conditions such as Alzheimer's disease and Fragile X syndrome.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AZ Therapies
This biopharmaceutical company develops therapies for neurodegenerative diseases, including Alzheimer's disease and ischaemic stroke, to treat patients and improve their cognitive health.
NeurOdys Therapeutics
This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.
Neumirna Therapeutics
This biotechnology company develops microRNA-based therapies to treat patients with neurological disorders, including drug-resistant epilepsy and Parkinson's disease.
Rodin Therapeutics
This biotechnology company develops small molecule therapies targeting epigenetic mechanisms to treat neurodegenerative and cognitive disorders for patients with diseases like Alzheimer's.
Korsana Biosciences
This biotechnology company develops brain-penetrant therapeutics for patients with neurodegenerative conditions such as Alzheimer's disease.
PharmatrophiX
The company develops small-molecule therapies targeting neurotrophin receptors for patients with Alzheimer's disease and other neurodegenerative disorders.
IAMA Therapeutics
This company develops small molecule drugs to treat neurodevelopmental and central nervous system disorders for patients with autism and epilepsy.
CuraSen Therapeutics
This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.
